CARZANIGA Laura (IT),КАРЦАНИГА Лаура (IT),RANCATI Fabio (IT),РАНКАТИ Фабио (IT),RIZZI Andrea (IT),РИЦЦИ Андреа (IT),LINNEY Ian (IT),ЛИННЕЙ Йен (IT),SCHMIDT Wolfgang (IT),ШМИДТ Вольфганг (IT),BARNES Mi
申请号：
RU2017141405
公开号：
RU0002709777C2
申请日:
2016.05.31
申请国别(地区):
RU
年份:
2019
代理人:
摘要：
FIELD: chemistry.SUBSTANCE: invention relates to organic chemistry and specifically to a compound of formula Iand pharmaceutically acceptable salts and solvates thereof. In the compounds of formula I: Y is selected from Y2 and Y1, which are divalent groups of formula or , where A1 and A2 independently absent or selected from a group consisting of (C1-C12)alkylene, (C3-C8)cycloalkylene； B is absent or selected from a group consisting of phenylene, optionally substituted with one group selected (C1-C6)alkoxy； C is absent or selected from a group consisting of -O-, -N(R7) - or represents one of the following groups C1-C2 , where R7 in each case independently represents H or is selected from a group consisting of a straight or branched (C1-C8)alkyl, (C3-C8)cycloalkyl, phenyl, phenyl(C1-C6)alkyl, (C1-C8)alkylcarbonyl, (C3-C8)cycloalkylcarbonyl, phenylcarbonyl, (C1-C8)alkoxycarbonyl, (C1-C8)alkylaminocarbonyl, (C1-C10)alkylsulphanyl and phenylsulphonyl； and where R7 can optionally be further substituted with one group selected from halogen, -CN, (C1-C8)alkyl, halogen (C1-C8)alkyl, phenyl, phenyl (C1-C6)alkyl, (C1-C8)alkoxy, phenyl(C1-C8)alkoxy, (C3-C8)cycloalkyl, which is a saturated monocyclic group, D is absent or is selected from a group consisting of (C1-C12)alkylene and phenylene； n, n', n'' and n''' in each case independently equal to 0 or integer from 1 to 3； E is absent or is selected from -O-, -NR7-, -NR7-C(O)-, -C(O)-NR7-； G is absent or is phenylene or thienylene, optionally substituted with one or two substitutes selected from a group consisting of halogen atoms, (C1-C10)alkyl, phenyl, halophenyl, thienyl and (C1-C10)alkoxy； L is absent or is a divalent group selected from -C(O)-, (C1-C8)alkylcarbonylen and (C2-C8) alkenylcarbonylene； i is 1 or 2； i' is equal to 1 or 2； R1 in each case is independently selected from hydrogen and halogen； s is equal to 0. Also disclosed are a pharmaceutical composition, use of the compound of formula I and a device.EFFECT: tec
